Skip to main content

CPAG Steering Committee

The role of the Coalition of Patient Advocacy Groups (CPAG) Steering Committee is to help facilitate the development of activities that will benefit the entire CPAG membership. Those activities include (but are not limited to) webinars, in-person meetings, and one-on-one connections with other CPAG members and RDCRN researchers.

CPAG Steering Committee members make a commitment to attend monthly one-hour teleconference meetings and to participate collaboratively with other members on projects identified to help accelerate research as outlined in the CPAG vision and mission statements. In addition, CPAG Steering Committee members disseminate information and decisions from the CPAG Steering Committee meetings to PIs and other individual consortium PAG members in a timely manner.

Patient Advocacy Group Representatives

2026-2027

ACT
Advancing Craniosynostosis Treatment Rare Diseases Consortium
BORN A HERO
Representative
Carolina Sommer
ARDVARC
Advancing Rare Disorders: Vascular mAlformation Research Network with CaNVAS
K-T Support Group
Representative
Mellenee Finger
ARISEN
Autoimmunity, Rasmussen’s, Inflammation & Status Epilepticus Research Network
Sumaira Foundation
Representative
Michael Devlin, Co-Chair
BDCRC
Batten Disease Clinical Research Consortium
Batten Disease Support & Research Association
Representative
Amy Fenton Parker
BBD
Brittle Bone Disorders
Osteogenesis Imperfecta Foundation, Inc.
Representative
Tracy Hart
CReATe
Clinical Research in ALS and Related Disorders for Therapeutic Development
Muscular Dystrophy Association
Representative
Brian Lin
CPIC
Congenital and Perinatal Infections Consortium
National CMV Foundation
Representative
Kristen Spytek
CEGIR
Consortium of Eosinophilic Gastrointestinal Disease Researchers
American Partnership for Eosinophilic Disorders
Representative
Deb Bruner
DSC
Developmental Synaptopathies Consortium
PTEN Foundation
Representative
Kristin Anthony
GLIA-CTN
The Global Leukodystrophy Initiative Clinical Trials Network
Chloe’s Fight Rare Disease Foundation
Representative
Erica Barnes
 
FamilieSCN2A Foundation
Representative
Melody Kiser
IMPACT
Initiation of a cohort to define pathogenic Mechanisms, Precision diagnosis And Complications of Thrombotic Microangiopathies: The IMPACT Study
United States Thrombotic Microangiopathy (USTMA)
Representative
Beth McGraw
MGNet
Myasthenia Gravis Rare Disease Network
Myasthenia Gravis Association
Representative
Allison Foss
NASCARR
Network for Advancing Sex Chromosome Aneuploidy Research Readiness
Association for X and Y Chromosome Variations (AXYS)
Representative
Erynn Fishman
NAMDC
North American Mitochondrial Disease Consortium
United Mitochondrial Disease Foundation (UMDF)
Representative
Philip Yeske
PFN-STRIDE
Pediatric Fungal Network STudy of Rare Invasive Fungal DisEases in Immunocompromised Pediatric Patients
MYCARE
Representative
Rob Purdie
PHEFREE
Phenylalanine Families and Researchers Exploring Evidence
National PKU Alliance (NPKUA)
Representative
Kelsey McQueen
RBDC
Rare Bronchiectatic Diseases Consortium
PCD Foundation
Representative
Michele Manion
ROAR
Rare Organic Acidemias Research Consortium
Propionic Acidemia Foundation
Representative
Jill Chertow
 
Organic Acidemia Association
Representatives
Kathy Stagni
Haley Stubbs, Co-Chair
SP-CERN
Spastic Paraplegia Centers of Excellence Research Network
Spastic Paraplegia Foundation, Inc.
Representative
Norma Pruitt